Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed grouped question UIN question first answered answering member label
tabling member	label

Search

755820

	registered interest
	date	04/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: North East
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, with reference to the latest statistical bulletin published by the Office for National Statistics on deaths related to drug poisoning, what steps he is taking to address the disproportionately high drug mortality rate in the North East.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	7218
	answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>Local authorities are responsible for commissioning effective drug and alcohol prevention and treatment services based on an assessment of local need. Public Health England (PHE) supports local authorities to do this, by providing bespoke data, value for money tools, topical briefings, and advice on good practice to help local authorities meet the needs of their local population. In the North East, PHE work to help local areas prevent drug-related deaths includes:</p><p> </p><p>- running forums and networks to facilitate regional groups of commissioners, providers and service users working together, sharing practice and disseminating new policy and guidance;</p><p>- offering bespoke support packages to local authorities where necessary; and</p><p>- promoting the use of naloxone and training people how to use it across the North East.</p><p>Nationally, PHE has issued advice on providing naloxone, published updated clinical guidelines for drug treatment and worked with a network of treatment providers to establish good practice guidance on managing drug-related death risk factors and to improve partnership between treatment providers and other healthcare services.</p><p>PHE has also established a new Public Health Outcomes Framework indicator on drug-related deaths to enable local areas benchmark their performance against others.</p><p> </p><p>Ongoing national work by PHE to help prevent drug-related deaths includes:</p><p> </p><p>- helping local authorities improve their drug-related death review process;</p><p>- helping local authorities increase the number of people with drug problems who are in drug treatment; and</p><p>- improving intelligence on the adverse health effects of drugs.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7238 7468 question first answered 12/09/2017 16:29:45 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

790988

	registered interest
	date	16/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, who is responsible for (a) appointing and (b) removing chief clinical officers of Clinical Commissioning Groups.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	113507
	answer	answer is ministerial correction date of answer 23/11/2017 answer text <p>Responsibility for the appointment and removal of a chief clinical officer lies with the clinical commissioning group and is undertaken within a framework set by NHS England.</p><p> </p><p>NHS England has produced guidance to support the employment of senior managers in clinical commissioning groups and is available at:</p><p><a href="https://www.england.nhs.uk/wp-content/uploads/2015/10/ccg-snr-appt-guidance.pdf" target="_blank">https://www.england.nhs.uk/wp-content/uploads/2015/10/ccg-snr-appt-guidance.pdf</a></p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2017 12:26:14 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

746358

	registered interest
	date	28/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Radiotherapy
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, which hospitals in England are allowed to use stereotactic radiosurgery to treat cerebral arteriovenous malformations and trigeminal neuralgia.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	1598
	answer	answer is ministerial correction date of answer 05/07/2017 answer text <p>A procurement process was completed in 2016 that resulted in 17 services being commissioned in England to deliver Stereotactic Radiosurgery/Radiotherapy (SRS/RT) treatments to patients with less complex clinical indications.</p><p> </p><p>Two of these services were also commissioned to deliver SRS/RT to rarer and more complex conditions, including cerebral arteriovenous malformations (AVMs) and trigeminal neuralgia. The two providers are Sheffield Teaching Hospitals NHS Foundation Trust, which takes referrals from neurosurgical centres in the north of England, and University College London Hospitals NHS Foundation Trust, which takes referrals from neurosurgical centres in the south of England.</p><p> </p><p>These conditions constitute a very small number of patients and the treatment requires specialist clinical expertise. Prior to 2016, although the majority of patients were receiving their SRS treatments in Sheffield, some individual centres were also treating very small numbers of these types of patients. The national review of this service was undertaken in order to ensure delivery of high-quality services.This resulted in the commissioning of two national centres, protecting and concentrating clinical expertise in the management of these rarer cases.</p><p> </p><p>In 2013-14 the contracted NHS England providers of SRS/RT were:</p><p> </p><p>- Addenbrookes Hospital, Cambridge;</p><p>- Bupa Cromwell, London;</p><p>- Derriford Hospital, Plymouth;</p><p>- Mount Vernon Hospital, Middlesex;</p><p>- Nova Healthcare/ Leeds Teaching Hospitals;</p><p>- Sheffield Teaching Hospitals;</p><p>- Royal Preston Hospital, Lancashire;</p><p>- Salford Royal Hospital, Salford/ The Christie, Manchester;</p><p>- St Bartholomew’s Hospital, London;</p><p>- Thornbury Gamma Knife Centre, Sheffield;</p><p>- The Walton Centre, Liverpool/Clatterbridge Centre for Oncology, Wirral;</p><p>- University Hospital Birmingham;</p><p>- University Hospital Bristol.</p><p> </p><p>Some of these centres would have provided treatments for AVMs and trigeminal neuralgia.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 1599 question first answered 05/07/2017 09:57:51 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

780540

	registered interest
	date	30/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the cost to the public purse is of the prescription exemption checking service.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	110330
	answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>There is no direct cost to the public purse for the prescription exemption checking service; it is entirely funded from the monies it recovers and the surplus is returned to NHS England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/11/2017 11:36:58 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

731345

	registered interest
	date	21/06/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Paracetamol
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what the cost to the public purse is for a prescription of paracetamol.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	327
	answer	answer is ministerial correction date of answer 29/06/2017 answer text <p>The net ingredient cost of paracetamol items prescribed in the United Kingdom and dispensed in England in each of the last five years is provided in the table below. The cost reported is at reimbursement prices. This does not take account of the margin that pharmacies earn on the medicines they dispense. This margin is subsequently taken into account as contributing towards the target level of funding for community pharmacy as part of the community pharmacy contractual framework.</p><p> </p><p>Net Ingredient Cost (NIC) per prescription items of paracetamol dispensed in England in each financial year within British National Formulary 4.7.1 non-opioid analgesics</p><p> </p><table><tbody><tr><td><p>Financial Year</p></td><td><p>NIC</p></td><td><p>Items</p></td><td><p>NIC per Item</p></td></tr><tr><td><p>2012/13</p></td><td><p>£73,793,906</p></td><td><p>21,963,186</p></td><td><p>£3.36</p></td></tr><tr><td><p>2013/14</p></td><td><p>£83,146,567</p></td><td><p>22,616,462</p></td><td><p>£3.68</p></td></tr><tr><td><p>2014/15</p></td><td><p>£86,884,281</p></td><td><p>23,326,577</p></td><td><p>£3.72</p></td></tr><tr><td><p>2015/16</p></td><td><p>£84,863,269</p></td><td><p>22,664,359</p></td><td><p>£3.74</p></td></tr><tr><td><p>2016/17</p></td><td><p>£70,187,088</p></td><td><p>21,740,142</p></td><td><p>£3.23</p></td></tr></tbody></table><p>Source: Prescription Cost Analysis (PCA)</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 325 question first answered 29/06/2017 09:37:10 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

755888

	registered interest
	date	04/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: North East
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to reduce the number of deaths from illegal drug use in the North East.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	7468
	answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>Local authorities are responsible for commissioning effective drug and alcohol prevention and treatment services based on an assessment of local need. Public Health England (PHE) supports local authorities to do this, by providing bespoke data, value for money tools, topical briefings, and advice on good practice to help local authorities meet the needs of their local population. In the North East, PHE work to help local areas prevent drug-related deaths includes:</p><p> </p><p>- running forums and networks to facilitate regional groups of commissioners, providers and service users working together, sharing practice and disseminating new policy and guidance;</p><p>- offering bespoke support packages to local authorities where necessary; and</p><p>- promoting the use of naloxone and training people how to use it across the North East.</p><p>Nationally, PHE has issued advice on providing naloxone, published updated clinical guidelines for drug treatment and worked with a network of treatment providers to establish good practice guidance on managing drug-related death risk factors and to improve partnership between treatment providers and other healthcare services.</p><p>PHE has also established a new Public Health Outcomes Framework indicator on drug-related deaths to enable local areas benchmark their performance against others.</p><p> </p><p>Ongoing national work by PHE to help prevent drug-related deaths includes:</p><p> </p><p>- helping local authorities improve their drug-related death review process;</p><p>- helping local authorities increase the number of people with drug problems who are in drug treatment; and</p><p>- improving intelligence on the adverse health effects of drugs.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7218 7238 question first answered 12/09/2017 16:29:46 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

780536

	registered interest
	date	30/10/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Prescriptions: Fees and Charges
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what steps he is taking to ensure the prescription exemption checking service distinguishes between people intentionally defrauding the NHS and cases where a prepayment prescription certificate expires; and whether fines should be imposed in both circumstances.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	110326
	answer	answer is ministerial correction date of answer 07/11/2017 answer text <p>Penalties are issued in accordance with The National Health Service (Penalty Charge) Regulations 1999 where an exemption claimed cannot be verified. The current penalty charges do not differentiate between fraud and error. When a patient does not pay for a prescription they have a responsibility to declare a valid exemption. Further communication campaigns will be carried out over the next 12 months to increase awareness and patient understanding of qualifying benefits and exemptions.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 07/11/2017 11:35:21 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

758731

	registered interest
	date	07/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	General Practitioners: Recruitment
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what progress the Government has made towards meeting its commitment to recruit 5,000 additional GPs by 2020.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	9605
	answer	answer is ministerial correction date of answer 15/09/2017 answer text <p>NHS England and Health Education England (HEE) are working together with the profession to increase the general practitioner (GP) workforce. This includes measures to boost recruitment into general practice, address the reasons why GPs are leaving the profession, and encourage GPs to return to practice.</p><p> </p><p>HEE has implemented a range of improvements to increase the number of GP training places to 3,250 each year. In 2016 3,019 new starters were recruited to training posts – this is the highest number of GP trainees ever.</p><p> </p><p>In August 2017, NHS England announced plans to accelerate its international recruitment programme, following a series of successful regional pilots. It aims to recruit at least 2,000 GPs from overseas over the next three years.</p><p> </p><p>To improve retention, NHS England has launched the GP Career Plus Scheme, to test a range of ways to offer flexibility and support to experienced GPs at risk of leaving general practice. This is in addition to the new GP Retention Scheme which offers funding to support doctors who can only work a limited number of sessions in general practice.</p><p> </p><p>Finally, in October 2016, NHS England announced a package of improvements to the GP Induction and Refresher Scheme to make it easier and quicker for qualified doctors to return to general practice.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 15/09/2017 12:32:59 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

790989

	registered interest
	date	16/11/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Clinical Commissioning Groups
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what powers he has to intervene in clinical commissioning groups in the event that there are concerns about commissioning policies.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	113503
	answer	answer is ministerial correction date of answer 23/11/2017 answer text <p>Clinical commissioning groups (CCGs) are independent organisations responsible for their own commissioning decisions. NHS England is accountable for ensuring that CCGs commission services that are high quality, and deliver value for money; this is assessed through mechanisms such as the CCG Improvement and Assessment Framework. Where performance concerns are identified, NHS England has the ability to exercise formal powers to either provide enhanced support to a CCG, or to issue legal directions where it believes that a CCG is failing or is at risk of failing to discharge its functions.</p><p> </p><p>The Department holds NHS England to account for improving the performance of CCGs. This is done through mechanisms such as the Mandate to NHS England.</p> answering member constituency Winchester answering member printed Steve Brine question first answered 23/11/2017 12:17:41 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris

755817

	registered interest
	date	04/09/2017
	answering body	Department of Health
	answering dept id	17
	answering dept short name	Health
	answering dept sort name	Health
	hansard heading	Drugs: North East
	house id	1
	legislature	25259 pref label House of Commons
	question text	To ask the Secretary of State for Health, what plans his Department has for a specialist drug treatment and recovery pilot programme in the North East.
	tabling member constituency	Easington
	tabling member printed	Grahame Morris
	uin	7238
	answer	answer is ministerial correction date of answer 12/09/2017 answer text <p>Local authorities are responsible for commissioning effective drug and alcohol prevention and treatment services based on an assessment of local need. Public Health England (PHE) supports local authorities to do this, by providing bespoke data, value for money tools, topical briefings, and advice on good practice to help local authorities meet the needs of their local population. In the North East, PHE work to help local areas prevent drug-related deaths includes:</p><p> </p><p>- running forums and networks to facilitate regional groups of commissioners, providers and service users working together, sharing practice and disseminating new policy and guidance;</p><p>- offering bespoke support packages to local authorities where necessary; and</p><p>- promoting the use of naloxone and training people how to use it across the North East.</p><p>Nationally, PHE has issued advice on providing naloxone, published updated clinical guidelines for drug treatment and worked with a network of treatment providers to establish good practice guidance on managing drug-related death risk factors and to improve partnership between treatment providers and other healthcare services.</p><p>PHE has also established a new Public Health Outcomes Framework indicator on drug-related deaths to enable local areas benchmark their performance against others.</p><p> </p><p>Ongoing national work by PHE to help prevent drug-related deaths includes:</p><p> </p><p>- helping local authorities improve their drug-related death review process;</p><p>- helping local authorities increase the number of people with drug problems who are in drug treatment; and</p><p>- improving intelligence on the adverse health effects of drugs.</p> answering member constituency Winchester answering member printed Steve Brine grouped question UIN 7218 7468 question first answered 12/09/2017 16:29:46 answering member 4067 label Biography information for Steve Brine
	tabling member	3973 label Biography information for Grahame Morris